This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbruck-Centrum Fur Molekulare Medizin. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Dagmar Ehrnhöfer: Innovator in Neurodegenerative Disease Treatment
Introduction
Dagmar Ehrnhöfer is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment and diagnosis of neurodegenerative diseases. Her work is vital in advancing medical science and improving patient outcomes.
Latest Patents
Dagmar holds 1 patent for her invention titled "Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases." This patent relates to pharmaceutical and diagnostic compositions, as well as the use of the active substances contained therein for preparing a pharmaceutical or diagnostic composition for the treatment or diagnosis of neurodegenerative disorders or amyloid diseases.
Career Highlights
Dagmar is associated with the Max-Delbrück-Centrum für Molekulare Medizin, where she has been instrumental in research and development. Her expertise in the field has positioned her as a key figure in the advancement of therapeutic solutions for complex medical conditions.
Collaborations
Some of her notable coworkers include Susanne Rautenberg and Jacqueline Walther. Their collaborative efforts contribute to the innovative research environment at their institution.
Conclusion
Dagmar Ehrnhöfer's work in developing pharmaceutical solutions for neurodegenerative diseases showcases her dedication to improving healthcare. Her contributions are essential in the ongoing fight against these challenging medical conditions.